Freeline Therapeutics Holdings plc ( FRLN) - Stock Earnings

FRLN Quarterly earnings

DateEarningsRevenue
2023Q1 -23.0 million USD 0 USD
2023Q2 -16.0 million USD 617000 USD
2023Q3 -12.1 million USD 5000 USD

FRLN Yearly earnings

DateEarningsRevenue
2021 -140.4 million USD 0 USD
2022 -89.0 million USD 617000 USD
2023 -49.9 million USD 622000 USD

FRLN

Price: $6.49

52 week price:
2.11
9.17

Earnings Per Share: -11.45 USD

P/E Ratio: -0.56

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United Kingdom

Volume: 189900

Market Capitalization: 28.2 million

Links: